BRWM
AXDX icon

B. Riley Wealth Management’s Accelerate Diagnostics AXDX Stock Holding History

B. Riley Wealth Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-47
Closed -$12K – 188
2015
Q2 		$12K Hold
47
– – 0.01% 704
2015
Q1 		$10K Hold
47
– – 0.01% 745
2014
Q4 		$9K Hold
47
– – 0.01% 747
2014
Q3 		$10K Hold
47
– – 0.01% 759
2014
Q2 		$12K Hold
47
– – 0.01% 776
2014
Q1 		$10K Buy
+47
New +$6.96K 0.01% 751

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Private Wealth Advisors
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Obermeyer Wealth Partners
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return

B. Riley Wealth Management's AXDX Position: Q3 2015 in Review

B. Riley Wealth Management sold out of Accelerate Diagnostics (AXDX) in Q3 2015, closing a stake of 47 shares — an estimated $12K sold.

B. Riley Wealth Management first reported a position in AXDX in Q1 2014 and held it in 6 quarters. The position peaked at $12K in Q2 2015. 88 funds tracked by Wall St. Rank hold AXDX as of Q3 2015.

  • B. Riley Wealth Management reported no remaining Accelerate Diagnostics position as of Q3 2015 after selling out during the quarter.
  • B. Riley Wealth Management sold 47 Accelerate Diagnostics shares in Q3 2015, an estimated $12K.
  • B. Riley Wealth Management first reported a position in Accelerate Diagnostics in Q1 2014 and held it in 6 quarters.
  • B. Riley Wealth Management's Accelerate Diagnostics position peaked at $12K in Q2 2015.
  • 88 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.